JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 25 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00013-07v1
81/13/7189    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth-Cross, J. K.
Right arrow Articles by Weiss, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth-Cross, J. K.
Right arrow Articles by Weiss, S. R.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00013-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Inhibition of the IFN-{alpha}/{beta} Response by Mouse Hepatitis Virus (MHV) at Multiple Levels

Jessica K. Roth-Cross, Luis Martínez-Sobrido, Erin P. Scott, Adolfo García-Sastre, and Susan R. Weiss*

Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104; Department of Microbiology, and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, NY 10029

* To whom correspondence should be addressed. Email: weisssr{at}mail.med.upenn.edu.


   Abstract

Mouse hepatitis virus (MHV) was used as a model to study the interaction of coronaviruses with the IFN-{alpha}/{beta} response. While MHV strain A59 appeared to induce IFN-{beta} gene transcription and low levels of nuclear translocation of the IFN-{beta} transcription factor IRF-3, MHV did not induce IFN-{beta} protein production during the course of infection in L2 mouse fibroblast cells. In addition, MHV was able to significantly decrease the level of IFN-{beta} protein induced by both Newcastle disease virus (NDV) and Sendai virus (SeV) infections, without targeting it for proteasomal degradation and without altering the nuclear translocation of IRF-3, IFN-{beta} mRNA production or stability. These results indicate that MHV infection causes an inhibition of IFN-{beta} production at a post-transcriptional level, without altering RNA or protein stability. In contrast, MHV induced IFN-{beta} mRNA and protein production in the brains of infected animals, suggesting that the inhibitory mechanisms observed in vitro are not enough to prevent IFN-{alpha}/{beta} production in vivo. Furthermore, MHV replication is highly resistant to IFN-{alpha}/{beta} action, as indicated by unimpaired MHV replication in L2 cells pretreated with IFN-{beta}. However, when L2 cells were co-infected with MHV and NDV in the presence of IFN-{beta}, NDV, but not MHV, replication was inhibited. Thus, rather than disarming the antiviral activity induced by IFN-{beta} pretreatment completely, MHV may be inherently resistant to some aspects of the antiviral state induced by IFN-{beta}. These findings show that MHV employs unique strategies to circumvent the IFN-{alpha}/{beta} response at multiple steps.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.